We performed this retrospective study of thyroid carcinoma patients for the purpose of investigating whether survivin expression is signficantly associated with poor prognosis and whether it may be used as a potential therapeutic target for thyroid tumors. Here, BIRC5 is linked to thyroid gland carcinoma.